ArticleTherapeutic advances in medical oncology2024

The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary center.

Kuan-Yu Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.